Diagnostic Genetic Testing for Hereditary Breast and Ovarian Cancer in Cancer Patients: Women's Looking Back on the Pre-Test Period and a Psychological Evaluation

Genetic Testing

Volumn 8, Issue 1, 2004, Pages 13-21

  Claes, Erna ^a   Evers Kiebooms, Gerry ^a,b   Boogaerts, Andrea ^a   Decruyenaere, Marleen ^a   Denayer, Lieve ^a   Legius, Eric ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b Center for Human Genetics   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CONTROL; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; DISTRESS SYNDROME; FAMILIAL CANCER; FEMALE; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC SCREENING; HETEROZYGOTE; HUMAN; INFORMATION PROCESSING; INTERVIEW; MAJOR CLINICAL STUDY; ONCOGENE; OVARY CANCER; PROGENY; PSYCHOLOGY; QUESTIONNAIRE; RELATIVE; RETROSPECTIVE STUDY; SELF REPORT;

EMPIRICAL APPROACH; GENETICS AND REPRODUCTION;

BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS;

EID: 1942530778     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/109065704323015996     Document Type: Article

References (32)

1. AMERICAN SOCIETY OF CLINICAL ONCOLOGY. (1996). Genetic testing for cancer susceptibility. J. Clin. Oncol. 14, 1730-1736.
2. ARRINDELL, W.A., and ETTEMA, J.H.M. (1986). SCL-90. Handleiding bij een multidimensionele psychopathologie-indicator. Swets & Zeitlinger, Lisse.
3. BAUM, A., FRIEDMAN, A.L., and ZAKOWSKI, S.G. (1997). Stress and genetic testing for disease risk. Health Psychol. 16, 8-19.
4. BISH, A., SUTTON, S., JACOBS, C., LEVENE, S., RAMIREZ, A., and HODGSON, S. (2002). No news is (not necessarily) good news: Impact of preliminary results for BRCA1 mutation searches. Genet. Med. 4, 353-358.
5. BLUMAN, L.G., RIMER, B.K., BERRY, D.A., BORSTELMANN, N., IGLEHART, J.D., REGAN, K., SCHILDKRAUT, J., and WINER, E.P. (1999). Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2. J. Clin. Oncol. 17, 1040-1046.
6. BONADONA, V., SALTEL, P., DESSEIGNE, F., MIGNOTTE, H., SAURIN, J.C., WANG, Q., SINILNIKOVA, O., GIRAUD, S., FREYER, G., PLAUCHU, H., PUISIEUX, A., and LASSET, C. (2002). Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result. Cancer Epidemiol. Biomark. Prev. 11, 97-104.
7. BROADSTROCK, M., MICHIE, S., GRAY, J., MACKAY, J., and MARTEAU, T.M. (2000). The psychological consequences of offering mutation searching in the family for those at risk of hereditary breast and ovarian cancer-a pilot study. Psycho-Oncol. 9, 537-548.
8. CAPPELLI, M., SURH, L., HUMPHREYS, L., VERMA, S., LOGAN, D., HUNTER, A., and ALLANSON, J. (1999). Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer. Clin. Genet. 55, 419-430.
9. CHAMPION, V.L. (1984). Instrument development for health belief model constructs. Adv. Nurs. Sci. 6, 73-85.
10. CLAES, E., EVERS-KIEBOOMS, G., BOOGAERTS, A., DECRUYENAERE, M., DENAYER, L., and LEGIUS, E. (2003). Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients. Am. J. Med. Genet. 116A, 11-19.
11. CROYLE, R.T., SMITH, K.R., BOTKIN, J.R., BATY, B., and NASH, J. (1997). Psychological responses to BRCA1 mutation testing: preliminary findings. Health Psychol. 16, 63-72.
12. DECRUYENAERE, M., EVERS-KIEBOOMS, G., DENAYER, L., WELKENHUYSEN, M., CLAES, E., LEGIUS, E., and DEMYTTENAERE, K. (2000). Predictive testing for hereditary breast and ovarian cancer: a psychological framework for pre-test counseling. Eur. J. Hum. Genet. 8, 130-136.
13. DORVAL, M., PATENAUDE, A.F., SCHNEIDER, K.A., KIEFFER, S.A., DIGIANNI, L., KALKBRENNER, K.L., BROMBERG, J.I., BASILI, L.A., CALZONE, K., STOPHER, J., WEBER, B.L., and GARBER, J.E. (2000). Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: Findings from p53 and BRCA1 testing programs. J. Clin. Oncol. 18, 2135-2142.
14. DUDOK DE WIT, A.C., TIBBEN, A., DUIVENVOORDEN, H.J., NIERMEIJER, M.F., and PASSCHIER, J. (1998). Predicting adaptation to presymptomatic DNA testing for late-onset disorders: who will experience distress? J. Med. Genet. 35, 745-754.
15. EVERS-KIEBOOMS, G., WELKENHUYSEN, M., CLAES, E., DECRUYENAERE, M.. and DENAYER, L. (2000). The psychological complexity of predictive testing for late onset neurogenetic diseases and hereditary cancers: Implications for multidisciplinary counseling and for genetic education. Soc. Sci. Med. 51, 831-841.
16. FRIEDMAN, L.C., WEBB, J.A., RICHARDS, C.S., LYNCH, G.R., KAPLAN, A.L., BRUNICARDI, F.C., and PLON, S.E. (1999). Psychological impact of receiving negative BRCA1 mutation test results in Ashkenazim. Genet. Med. 1, 74-79.
17. GOELEN, G., RIGO, A., BONDUELLE, M., and DE GRÈVE, J. (1999). Moral concerns of different types of patients in clinical BRCA1/2 gene mutation testing. J. Clin. Oncol. 17, 1595-1600.
18. HALLOWELL, N., FOSTER, C., ARDERN-JONES, A., EELES, R., MURDAY, V., and WATSON, M. (2002). Genetic testing for women previously diagnosed with breast/ovarian cancer: examining the impact of BRCA1 and BRCA2 mutations searching. Genet. Test. 6, 79-87.
19. HOROWITZ, M.J., WILNER, N., and ALVAREZ, W. (1979). Impact of Event Scale: a measure of subjective stress. Psychosom. Med. 41, 209-218.
20. LERMAN, C., and CROYLE, R.T. (1996). Emotional and behavioral responses to genetic testing for susceptibility to cancer. Oncology 10, 191-202.
21. LERMAN, C., NAROD, S., SCHULMAN, K., HUGHES, C., GOMEZ-CAMINERO, A., BONNEY, G., GOLD, K., TROCK, B., MAIN, D., LYNCH, J., FULMORE, C., SNYDER, C., LEMON, S.J., CONWAY, T., TONIN, P., LENOIR, G., and LYNCH. H. (1996). BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. J. Am. Med. Assoc. 275, 1885-1892.
22. LODDER, L.N., FRETS, P.G., TRIJSBURG, R.W., MEIJERS-HEIJBOER, E.J., KLIJN, J.G., SEYNAEVE, C., VAN GEEL, A.N., TILANUS, M.M., BARTELS, C.C., VERHOOG, L.C., BREKELMANS, C.T., BURGER, C.W., NIERMEIJER, M.F. (2002). One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery). Breast Cancer Res. Ther. 73, 97-112.
23. MEISER, B., BUTOW, P., FRIEDLANDER, M., BARRATT, A., SCHNIEDEN, V., WATSON, M., BROWN, J., and TUCKER, K. (2002). Psychological impact of genetic testing in women from high-risk breast cancer families. Eur. J. Cancer 38, 2025-2031.
24. PETERSON, S.K., GRITZ, E.R., VERNON, S.W., MARNAI, S.K., REIGER, P.T., WARD, P.A., and MILS, G.B. (1999). Genetic counseling and testing for hereditary breast/ovarian cancer: the impact of receiving positive and uninformative results. Am. J. Hum. Genet. 65 (suppl. Oktober), 1775.
25. PHILLIPS, K.A., WARNER, E., MESCHINO, W.S., HUNTER, J., ABDOLELL, M., GLENDON, G., ANDRULIS, I.L., and GOODWIN, P.J. (2000). Perceptions of Ashkenazi Jewish breast cancer patients on genetic testing for mutations in BRCA1 and BRCA2. Clin. Genet. 57, 376-383.
26. PONDER, M., and GREEN, J. (1996). BRCA1 testing: some issues in moving from research to service. Psycho-Oncol. 5, 223-232.
27. RANDALL, J., BUTOW, P., KIRK, J., and TUCKER, K. (2001). Psychological impact of genetic counseling and testing in women previously diagnosed with breast cancer. Int. Med. J. 31, 397-405.
28. SCHREURS, P.J., VAN DE WILLIGE, G., TELLEGEN, B., and BROSSCHOT, J.F. (1998). De Utrechtse Copinglijst. Omgaan met problemen en gebeurtenissen. Swets & Zeitlinger, Lisse.
29. SCHWARTZ, M.D., PESHKIN, B.N., HUGHES, C., MAIN, D., ISAACS, C., and LERMAN, C. (2002). Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample. J. Clin. Oncol. 20, 514-520.
30. TERCYAK, K.P., LERMAN, C., PESHKIN, B., HUGHES, C., MAIN, D., ISAACS, C., and SCHWARTZ, M.D. (2001). Effects of copingstyle and BRCA1 and BRCA2 test results on anxiety among women participating in genetic counseling and testing for breast and ovarian cancer risk. Health Psychol. 20, 217-222.
31. VAN DER PLOEG, H.M., DEFARES, P.B., and SPIELBERGER, C.D. (1980). Handleiding bij de Zeflbeoordelingsvragenlijst: een Nederlandstalige bewerking van de Spielberger State-Trait Anxiety Inventory. Swets & Zeitlinger, Lisse.
32. WOOD, M.E., MULLINEAUX, L., KULCHAK RAHM, A., FAIRCLOUGH, D., and WENZEL, L. (2000). Impact of BRCA1 testing on women with cancer: a pilot study. Genet. Test. 4, 265-272.